Drugs / KD01
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07359235 | Nov 2024 → Dec 2028 expected | urinary bladder cancer | Tongji Hospital | Recruiting | No outcome recorded |
| Phase 1 | NCT06552598 | Apr 2024 → Apr 2028 expected | cervical cancer, endometrial cancer | Tongji Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KD01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07359235 ↗ |
| Route | Other | “Local administration” NCT06552598 ↗ |